Article Information
History
- December 16, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jesper Dahl1,*,
- German Tapia2,
- Håkon Bøås1,
- Inger Johanne Landsjøåsen Bakken3 and
- Hanne Løvdal Gulseth2
- 1Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
- 2Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
- 3Division of Health Data and Digitalisation, Norwegian Institute of Public Health, Trondheim, Norway
- ↵*Corresponding author:
Jesper Dahl, Norwegian Institute of Public Health, P.O. Box 222, 0213 Oslo, Norway, E-mail: jesper.dahl{at}fhi.no, Phone: +47 21 07 70 00
Posted December 16, 2024.
COVID-19 mRNA-vaccination and all-cause mortality in the adult population in Norway during 2021-2023: a population-based cohort study
